NSE · Healthcare · updated 17 Nov 2026, 4:46 pm IST
AI summary5 points
Aarti Drugs closed at ₹507.35 on 13 Nov 2026, -0.28% on the day and 6.9% below its 52-week high.
The stock is +13.6% over five sessions, +28.0% over a month and +33.4% over six months.
Read all 5 points
Delivery was 21% of the last session's volume against a 20-session average of 35%.
On 9 Nov, 5 clients bought and sold the same day, ₹217.11 Cr in all; 12 bulk or block deals were disclosed in 30 days.
It ranks 2nd of 13 Healthcare stocks on one-month return; Sai Life Sciences led with +38.8%.
Written by Claude from this page's own figures at 15 Nov, 06:05 am IST — every number checked against the page. A summary, not advice.
Last price
₹501.25
Change
-1.20%
Volume
5,47,208
vs avg volume
0.16x
BIG MONEY In this stock, the last 30 days
In and out the same day: on 9 Nov, 5 clients (MICROCURVES TRADING PRIVATE LIMITED, QE SECURITIES LLP, ALPHAGREP SECURITIES PRIVATE LIMITED…) bought and sold, ₹217.11 Cr in all.
In and out the same day: on 28 Oct, 1 client (JUNOMONETA FINSOL PRIVATE LIMITED) bought and sold, ₹22.54 Cr in all.
From the exchange's bulk and block deal disclosures and NSE's daily file. The client's kind is read from its name. A record of trades, not a view on them. All big deals →
Aarti Drugs Ltd. trades on the NSE under the symbol AARTIDRUGS and is classified under Healthcare (microcap cap by NSE's index grouping). It is a constituent of NIFTY MICROCAP 250. NSE's securities master records its listing date as 19 Sep 2003.
On 16 Nov 2026 the stock closed at ₹501.25, -1.2% on the day. Over the past year it has traded between ₹319.75 and ₹545.05; the current price sits 81% of the way up that range, 8.0% below the 52-week high. The move has been +0.3% over five sessions, +25.5% over a month, +19.0% over three months, +30.9% over six months.
Volume in the last session was 0.2× the stock's 20-session average — unusually light. 26% of that volume was taken as delivery, against a 20-session average of 33%. Delivery has fallen from about 48% to 32% over the last month.
No promoter or insider trades have been filed for the stock in the last 90 days. The exchange disclosed 12 bulk or block deals in the last 30 days (6 buy, 6 sell), including ALPHAGREP SECURITIES PRIVATE LIMITED, HRTI PRIVATE LIMITED, JUNOMONETA FINSOL PRIVATE LIMITED.
Among 13 Healthcare stocks tracked here, its one-month return ranks 3rd; the strongest over the month was Sai Life Sciences Ltd. (+29.0%).
A weaker rupee raises the rupee value of dollar revenue for IT services and pharmaceutical exporters, and raises the rupee cost of imported crude for refiners and oil marketers, with Brent at $95.47 a barrel on the…
Information Technology · Oil Gas & Consumable Fuels · HealthcareHDFC Sky (PTI) ↗
The US is the largest market for Indian textile, auto-component, pharmaceutical and engineering exporters. A tariff gap against Vietnam, Bangladesh or China shifts orders toward Indian suppliers; the reverse sends them…
Textiles · Automobile and Auto Components · Healthcare · Capital GoodsThePrint ↗
A margin cap cuts the gap between the price a drugmaker sells at and the MRP, so the trade margin earned by distributors, pharmacies and hospital pharmacies shrinks most. Drugmakers with oncology portfolios may have to…
Delivery is the share of traded volume actually settled into demat
accounts rather than squared off intraday — the difference between accumulation
and churn. How it is used.
Bulk & block deals
Exchange-disclosed transactions, reported as published.